GRDN

insider transactions

Guardian Pharmacy Services, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 365d

-14.1M

0 buy · 14.1M sell

Net value · 365d

-$419.3M

$0 in · $419.3M out

Sentiment · 365d

Net selling

0% buying · 100% selling

Open-market trades · 365d

0 buy · 14.1M sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
May 5, 26

Mary Sue Patchett

Director

$0

4.0K sh

Own +36%
Grant·A
May 5, 26

Randall J Lewis

Director

$0

4.0K sh

Own +36%
Grant·A
May 5, 26

Steven D Cosler

Director

$0

4.0K sh

Own +16%
Exercise·M
Mar 28, 26

Pharmacy Investors, LLC

Other

—

1.4M sh

Own New
Exercise·M
Mar 28, 26

Pharmacy Investors, LLC

Other

—

1.4M sh

Own +136%
Exercise·M
Mar 28, 26

Thomas J Salentine Jr

Director, 10% Owner

—

6.1M sh

Own New
Exercise·M
Mar 28, 26

Thomas J Salentine Jr

Director, 10% Owner

—

6.1M sh

Own +136%
Exercise·M
Mar 28, 26

David K Morris KEY

Executive Vice President and …

—

641.9K sh

Own +64186900%
Exercise·M
Mar 28, 26

David K Morris KEY

Executive Vice President and …

—

641.9K sh

Own +252%
Exercise·M
Mar 28, 26

Kendall Forbes KEY

Executive Vice President, Sal…

—

608.6K sh

Own New
Exercise·M
Mar 28, 26

Kendall Forbes KEY

Executive Vice President, Sal…

—

608.6K sh

Own +134%
Exercise·M
Mar 28, 26

Cardinal Equity Fund, L.P.

Other

—

471.1K sh

Own New
Exercise·M
Mar 28, 26

Cardinal Equity Fund, L.P.

Other

—

471.1K sh

Own +136%
Exercise·M
Mar 28, 26

Fred Burke KEY

President and Chief Executive…

—

1.3M sh

Own New
Exercise·M
Mar 28, 26

Fred Burke KEY

President and Chief Executive…

—

1.3M sh

Own +155%
Exercise·M
Mar 28, 26

Bindley Capital Partners I, LLC

10% Owner

—

6.1M sh

Own New
Exercise·M
Mar 28, 26

Bindley Capital Partners I, LLC

10% Owner

—

6.1M sh

Own +136%
Exercise·M
Mar 28, 26

BINDLEY WILLIAM E

Director, 10% Owner

—

6.1M sh

Own New
Exercise·M
Mar 28, 26

BINDLEY WILLIAM E

Director, 10% Owner

—

6.1M sh

Own +136%
Exercise·M
Mar 28, 26

John Ackerman

Director

—

471.1K sh

Own New
Exercise·M
Mar 28, 26

John Ackerman

Director

—

1.4M sh

Own New
Exercise·M
Mar 28, 26

John Ackerman

Director

—

471.1K sh

Own +136%
Exercise·M
Mar 28, 26

John Ackerman

Director

—

1.4M sh

Own +136%
Sell·S
Mar 20, 26

David K Morris KEY

Executive Vice President and …

$5.6M

187.9K sh · $29.68

Own -42%
Sell·S
Mar 20, 26

Pharmacy Investors, LLC

Other

$24.6M

827.6K sh · $29.68

Own -44%
Sell·S
Mar 20, 26

Thomas J Salentine Jr

Director, 10% Owner

$106.0M

3.6M sh · $29.68

Own -44%
Sell·S
Mar 20, 26

Kendall Forbes KEY

Executive Vice President, Sal…

$10.3M

346.7K sh · $29.68

Own -43%
Sell·S
Mar 20, 26

Cardinal Equity Fund, L.P.

Other

$8.2M

275.7K sh · $29.68

Own -44%
Sell·S
Mar 20, 26

Fred Burke KEY

President and Chief Executive…

$19.9M

671.4K sh · $29.68

Own -44%
Sell·S
Mar 20, 26

Bindley Capital Partners I, LLC

10% Owner

$106.0M

3.6M sh · $29.68

Own -44%
Sell·S
Mar 20, 26

BINDLEY WILLIAM E

Director, 10% Owner

$106.0M

3.6M sh · $29.68

Own -44%
Sell·S
Mar 20, 26

John Ackerman

Director

$8.2M

275.7K sh · $29.68

Own -44%
Sell·S
Mar 20, 26

John Ackerman

Director

$24.6M

827.6K sh · $29.68

Own -44%
Grant·A
Mar 1, 26

David K Morris KEY

Executive Vice President and …

$0

9.0K sh

Own +2%
Grant·A
Mar 1, 26

Kendall Forbes KEY

Executive Vice President, Sal…

$0

9.0K sh

Own +1%
Grant·A
Feb 11, 26

David K Morris KEY

Executive Vice President and …

$0

50.0K sh

Own New
Grant·A
Feb 11, 26

Kendall Forbes KEY

Executive Vice President, Sal…

$0

50.0K sh

Own New
Grant·A
Feb 11, 26

Fred Burke KEY

President and Chief Executive…

$0

75.0K sh

Own New
Grant·A
Jan 30, 26

Steven D Cosler

Director

$65.6K

1.6K sh · $41.82

Own +2%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
May 5, 2026	Mary Sue Patchett	Director	Grant A	4.0K	+36%	—	$0
May 5, 2026	Randall J Lewis	Director	Grant A	4.0K	+36%	—	$0
May 5, 2026	Steven D Cosler	Director	Grant A	4.0K	+16%	—	$0
Mar 28, 2026	Pharmacy Investors, LLC	Other	Exercise M	1.4M	New	—	—
Mar 28, 2026	Pharmacy Investors, LLC	Other	Exercise M	1.4M	+136%	—	—
Mar 28, 2026	Thomas J Salentine Jr	Director, 10% Owner	Exercise M	6.1M	New	—	—
Mar 28, 2026	Thomas J Salentine Jr	Director, 10% Owner	Exercise M	6.1M	+136%	—	—
Mar 28, 2026	David K Morris KEY	Executive Vice President and Chief Financial Officer	Exercise M	641.9K	+64186900%	—	—
Mar 28, 2026	David K Morris KEY	Executive Vice President and Chief Financial Officer	Exercise M	641.9K	+252%	—	—
Mar 28, 2026	Kendall Forbes KEY	Executive Vice President, Sales & Operations	Exercise M	608.6K	New	—	—
Mar 28, 2026	Kendall Forbes KEY	Executive Vice President, Sales & Operations	Exercise M	608.6K	+134%	—	—
Mar 28, 2026	Cardinal Equity Fund, L.P.	Other	Exercise M	471.1K	New	—	—
Mar 28, 2026	Cardinal Equity Fund, L.P.	Other	Exercise M	471.1K	+136%	—	—
Mar 28, 2026	Fred Burke KEY	President and Chief Executive Officer	Exercise M	1.3M	New	—	—
Mar 28, 2026	Fred Burke KEY	President and Chief Executive Officer	Exercise M	1.3M	+155%	—	—
Mar 28, 2026	Bindley Capital Partners I, LLC	10% Owner	Exercise M	6.1M	New	—	—
Mar 28, 2026	Bindley Capital Partners I, LLC	10% Owner	Exercise M	6.1M	+136%	—	—
Mar 28, 2026	BINDLEY WILLIAM E	Director, 10% Owner	Exercise M	6.1M	New	—	—
Mar 28, 2026	BINDLEY WILLIAM E	Director, 10% Owner	Exercise M	6.1M	+136%	—	—
Mar 28, 2026	John Ackerman	Director	Exercise M	471.1K	New	—	—
Mar 28, 2026	John Ackerman	Director	Exercise M	1.4M	New	—	—
Mar 28, 2026	John Ackerman	Director	Exercise M	471.1K	+136%	—	—
Mar 28, 2026	John Ackerman	Director	Exercise M	1.4M	+136%	—	—
Mar 20, 2026	David K Morris KEY	Executive Vice President and Chief Financial Officer	Sell S	187.9K	-42%	$29.68	$5.6M
Mar 20, 2026	Pharmacy Investors, LLC	Other	Sell S	827.6K	-44%	$29.68	$24.6M
Mar 20, 2026	Thomas J Salentine Jr	Director, 10% Owner	Sell S	3.6M	-44%	$29.68	$106.0M
Mar 20, 2026	Kendall Forbes KEY	Executive Vice President, Sales & Operations	Sell S	346.7K	-43%	$29.68	$10.3M
Mar 20, 2026	Cardinal Equity Fund, L.P.	Other	Sell S	275.7K	-44%	$29.68	$8.2M
Mar 20, 2026	Fred Burke KEY	President and Chief Executive Officer	Sell S	671.4K	-44%	$29.68	$19.9M
Mar 20, 2026	Bindley Capital Partners I, LLC	10% Owner	Sell S	3.6M	-44%	$29.68	$106.0M
Mar 20, 2026	BINDLEY WILLIAM E	Director, 10% Owner	Sell S	3.6M	-44%	$29.68	$106.0M
Mar 20, 2026	John Ackerman	Director	Sell S	275.7K	-44%	$29.68	$8.2M
Mar 20, 2026	John Ackerman	Director	Sell S	827.6K	-44%	$29.68	$24.6M
Mar 1, 2026	David K Morris KEY	Executive Vice President and Chief Financial Officer	Grant A	9.0K	+2%	—	$0
Mar 1, 2026	Kendall Forbes KEY	Executive Vice President, Sales & Operations	Grant A	9.0K	+1%	—	$0
Feb 11, 2026	David K Morris KEY	Executive Vice President and Chief Financial Officer	Grant A	50.0K	New	—	$0
Feb 11, 2026	Kendall Forbes KEY	Executive Vice President, Sales & Operations	Grant A	50.0K	New	—	$0
Feb 11, 2026	Fred Burke KEY	President and Chief Executive Officer	Grant A	75.0K	New	—	$0
Jan 30, 2026	Steven D Cosler	Director	Grant A	1.6K	+2%	$41.82	$65.6K

About GRDN insider trading

This page tracks insider transactions for Guardian Pharmacy Services, Inc. (GRDN) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.